Synthesis, QSAR and anti-HIV activity of new 5-benzylthio-1,3,4-oxadiazoles derived from α-amino acids

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 26, Issue 5, 2011, Pages 668-680

  Syed, Tayyaba ^a   Akhtar, Tashfeen ^a   Al Masoudi, Najim A ^b,c   Jones, Peter G ^d   Hameed, Shahid ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b UNIVERSITY OF BASRAH   (Iraq)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

amino acids; 3,4 oxadiazoles; 5 benzylthio 1; Anti HIV activity; QSAR

Indexed keywords

5 BENZYLTHIO 1,3,4 OXADIAZOLE; ALANINE; ALPHA AMINO ACID; ANTIVIRUS AGENT; HYDRAZIDE; METHIONINE; OXADIAZOLE DERIVATIVE; PHENYLALANINE; UNCLASSIFIED DRUG;

ALKYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CYCLIZATION; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION; X RAY CRYSTALLOGRAPHY;

ANTIVIRAL AGENTS; CRYSTALLOGRAPHY, X-RAY; HIV; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; OXADIAZOLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SULFHYDRYL COMPOUNDS; SULFONAMIDES;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 80052830960     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2010.546792     Document Type: Article

References (26)

1. Hijikata M, Ohta Y, Baba K. Iwata K, Matsumoto M, Mishiro S, Kanai K. Instability of the NS5A ISDR of hepatitis C virus during natural course: take-over of wild type by mutant type or vice-versa driven by immune pressure. Hepatology Res 1998;11:19-25. (Pubitemid 28234440)
2. Bartenschlager R, Lohmann V. Novel cell culture systems for the hepatitis C virus. Antiviral Res 2001;52:1-17. (Pubitemid 32800687)
3. Zareef M, Iqbal R, Al-Masoudi NA, Zaidi JH, Arfan M, Shahzad SA. Synthesis, anti-HIV and antifungal activity of new benzensulphonamides bearing 2,5-disubstituted 1,3,4-oxadiazole moiety. Phosphorus Sulfur Silicon Relat Elem 2007;182:281-298.
4. Iqbal R, Zareef M, Ahmed S, Zaidi JH, Arfan M, Shafque M, Al-Masoudi NA. Synthesis, antimicrobial and anti-HIV activity of some novel benzenesulfonamides bearing 2,5-disubstituted-1,3,4-oxadiazole moiety. J Chin Chem Soc 2006;53:689-696.
5. El-Emam AA, Al-Deeb OA, Al-Omar M, Lehmann J. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4- oxadiazoline-2-thiones. Bioorg Med Chem 2004;12:5107-5113. (Pubitemid 39206283)
6. Johns BA, Weatherhead JG, H., Allen SH, Tompson JB, Garvey EP, Foster SA, Jefrey JL, Miller WH. Te use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorg Med Chem Lett 2009;19:1802-1806.
7. Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JV, Berger DS et al.; STARTMRK investigators. Safety and efcacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet 2009;374:796-806.
8. Yan S, Appleby T, Larson G, Wu JZ, Hamatake RK, Hong Z et al. Tiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study. Bioorg Med Chem Lett 2007;17:1991-1995. (Pubitemid 46367660)
9. Yannopoulos CG, Xu P, Ni F, Chan L, Pereira OZ, Reddy TJ et al. HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESY. Bioorg Med Chem Lett 2004;14:5333-5337. (Pubitemid 39348924)
10. Selvam P, Murugesh N, Chandramohan M, Sidwell RW, Wandersee MK, Smee D F. Anti-infuenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives. Antiviral Chem Chemother 2006;17:269-274. (Pubitemid 44901471)
11. Li X, Yang X, Liang X, Kai Z, Yuan H, Yuan D, Zhang J, Wang R, Ran F, Qi S, Ling Y, Chen F, Wang D. Synthesis and biological activities of 2-oxocycloalkylsulfonamides Bioorg Med Chem 2008;16:4538-4544. (Pubitemid 351539031)
12. Vermeire K, Schols D. Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs. J Antimicrob Chemother 2005;56:270-272. (Pubitemid 41158511)
13. Akhtar T, Hameed S, Al-Masoudi NA, Loddo R, La Colla P. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2- thione. Acta Pharm 2008;58:135-149. (Pubitemid 351777172)
14. Akhtar T, Hameed S, Al-Masoudi NA, Khan KM. Synthesis, and anti-HIV activity of new chiral 1,2,4-triazoles and 1,3,4-thiadiazoles. Heteroatom Chem 2007;18:316-322. (Pubitemid 46716670)
15. Zahid M, Yasin KA, Akhtar T, Rama NH, Hameed S, Al-Masoudi NA., Loddo R, La Colla P. New 2-(4-aryl)-5-(2-adamantylthiazol-4-yl)-1,3,4-oxadiazoles as potential antiproliferative and antiviral agents, ARKIVOC 2009;xi: 85-93.
16. Serwar M, Akhtar T, Hameed S, Khan KM. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1,2,4- triazole-3-(4H)-thione. ARKIVOC 2009;vii:210-221.
17. Akhtar T, Hameed S, Khan KM, Choudhary MI. Syntheses, urease inhibition, and antimicrobial studies of some chiral 3-substituted-4-amino-5-thioxo-1H,4H-1, 2,4-triazoles. Med Chem 2008;4:539-543.
18. Stewart JJP. Optimization of parameters for semi-empirical methods. I Method J Comput Chem 1989;10:209-220.
19. Sheldrick GMA. Short history of SHELX. Acta Cryst 2008;A64:112-122.
20. Zareef M, Iqbal R, De Dominguez NG, Rodrigues J, Zaidi JH, Arfan M, Supuran CT. Synthesis andantimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties. J Enz Inhib Med Chem 2007;22:301-308. (Pubitemid 47225723)
21. Zarghi A, Faizi M, Shafaghi B, Ahadian A, Khojastehpoor HR, Zanganeh V et al. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4- oxadiazoles as benzodiazepine receptor agonists. Bioorg Med Chem Lett 2005;15:3126-3129.
22. Koparir M, Cetin A, Cansiz A. 5-Furan-2-yl[1,3,4]oxadiazole-2-thiol, 5-furan-2yl-4H [1,2,4] triazole-3-thiol and their thiol-thione tautomerism. Molecules 2005;10:475-480. (Pubitemid 40632788)
23. Hargrave KD, Proudfoot JR, Grozinger KG, Cullen E, Kapadia SR, Patel UR et al. Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo-and dipyridodiazepinones. J Med Chem 1991;34:2231-2241.
24. Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC et al. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic efect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985;82:7096-7100. (Pubitemid 16209699)
25. Fletcher P. Practical Methods of Optimization. New York: Wiley, 1990.
26. Rui OM, Qian L. I. 2D-QSAR studies on phenoxybenzoic acid derivatives: A novel class of 5α-reductase inhibitors. Chinese J Struct Chem 2008; 27: 105-111.